REPAGLINIDE EVOLUGEN 2 mg, tablet 90 tablets
Active ingredients: Repaglinide
Commercialized according to BDPMDispensing in France: Prescription only
Tablet90 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- REPAGLINIDE EVOLUGEN 2 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) polyamide aluminium PVC-Aluminium de 90 comprimé(s)
- Marketing authorisation holder
- EVOLUPHARM
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 9 Jan 2017
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66765727CIP72679183CIP133400926791834Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RÉPAGLINIDEcomprimé | 2 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.